Abstract:Short major histocompatibility complex (MHC) class I (MHC-I)-restricted peptides contain the minimal biochemical information to induce antigen (Ag)-specific CD8+ cytotoxic T cell responses but are generally ineffective in doing so. To address this, we developed a cobalt–porphyrin (CoPoP) liposome vaccine adjuvant system that induces rapid particleization of conventional, short synthetic MHC-I epitopes, leading to strong cellular immune responses at nanogram dosing. Along with CoPoP (to induce particle formation of peptides), synthetic monophosphoryl lipid A (PHAD) and QS-21 immunostimulatory molecules were included in the liposome bilayer to generate the "CPQ" adjuvant system. In mice, immunization with a short MHC-I-restricted peptide, derived from glycoprotein 70 (gp70), admixed with CPQ safely generated functional, Ag-specific CD8+ T cells, resulting in the rejection of multiple tumor cell lines, with durable immunity. When cobalt was omitted, the otherwise identical peptide and adjuvant components did not result in peptide binding and were incapable of inducing immune responses, demonstrating the importance of stable particle formation. Immunization with the liposomal vaccine was well-tolerated and could control local and metastatic disease in a therapeutic setting. Mechanistic studies showed that particle-based peptides were better taken up by antigen-presenting cells, where they were putatively released within endosomes and phagosomes for display on MHC-I surfaces. On the basis of the potency of the approach, the platform was demonstrated as a tool for in vivo epitope screening of peptide microlibraries comprising a hundred peptides.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c07680?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c07680</a>.Supporting methods; figures showing synthesis schemes, 1H and 13C NMR and mass spectra, HPLC traces, cryo-electron micrographs, peptide bindings to liposomes, gating results, CPQ/A5 vaccination effects, impacts of PHAD, QS-21 and antigens, optional solubility tag effects, QS-21 and antigen dosage effects, liposomes draining, vaccine injection effects at multiple sites, macrophage uptake, PoP lipids coated on silica beads, liposome/peptide complexes, A5 with 2 his-tag released, fluorescence integrity, various length impacts of A5, QS-21 and peptide dose effects, CPQ as platform, details of peptide binding, cytotoxicities, Rragc385 DNA sequencing, and antitumor efficacy; tables listing 1H shifts and assignments, ICP analysis, representative UV–vis absorptions, polydispersities and ζ potentials, A5 peptides, and properties of A5 related and synthetic peptides (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c07680/suppl_file/nn0c07680_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Magnetic Metal Micelles for Enhanced Delivery of Self-Immolating CD8<SUP>+</SUP> T-Cell Epitopes for Cancer Immunotherapy

Biomimetic Metallacage Nanoparticles with Aggregation-Induced Emission for NIR-II Fluorescence Imaging-Guided Synergistic Immuno-Phototherapy of Tumors

Anticancer Vaccination with Immunogenic Micelles That Capture and Release Pristine CD8+ T-Cell Epitopes and Adjuvants

Magnetic Delivery of Antigen‐Loaded Magnetic Liposomes for Active Lymph Node Targeting And Enhanced Anti‐Tumor Immunity

Magnetic Delivery of Antigen‐Loaded Magnetic Liposomes for Active Lymph Node Targeting and Enhanced Anti‐Tumor Immunity (Adv. Healthcare Mater. 32/2023)

Magnetic Nanoparticles Enhance the Cellular Immune Response of Dendritic Cell Tumor Vaccines by Realizing the Cytoplasmic Delivery of Tumor Antigens

CO-DELIVERY of glutamic acid-extended peptide antigen and imidazoquinoline TLR7/8 agonist via ionizable lipid nanoparticles induces protective anti-tumor immunity

Engineering Magnetosomes for High-Performance Cancer Vaccination.

Ph-Responsive Biomimetic Polymeric Micelles As Lymph Node-Targeting Vaccines for Enhanced Antitumor Immune Responses.

Biomimetic Magnetosomes As Versatile Artificial Antigen-Presenting Cells to Potentiate T-Cell-Based Anticancer Therapy

In Vivo Expansion of Melanoma-Specific T Cells Using Microneedle Arrays Coated with Immune-Polyelectrolyte Multilayers

Manganese Coordination Micelles That Activate Stimulator of Interferon Genes and Capture In Situ Tumor Antigens for Cancer Metalloimmunotherapy

Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy

Synthetic Polymeric Mixed Micelles Targeting Lymph Nodes Trigger Enhanced Cellular and Humoral Immune Responses.

Magnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer Immunotherapy.

Tailoring Polymeric Hybrid Micelles with Lymph Node Targeting Ability to Improve the Potency of Cancer Vaccines

Coordinating Antigen Cytosolic Delivery and Danger Signaling to Program Potent Cross-Priming by Micelle-Based Nanovaccine

A Potent Cancer Vaccine Adjuvant System for Particleization of Short, Synthetic CD8 + T Cell Epitopes

A composite peptide-supramolecular microneedle system for melanoma immunotherapy

Micelle-like Nanoparticles for Drug Delivery and Magnetically Enhanced Tumor Chemotherapy

Cell Membrane-Encapsulated Magnetic Nanoparticles for Enhancing Natural Killer Cell-Mediated Cancer Immunotherapy.